Peripheral facial nerve palsy associated with COVID-19

Journal of NeuroVirology - Tập 26 - Trang 941-944 - 2020
Marco A. Lima1,2, Marcus Tulius T. Silva1,3, Cristiane N. Soares4, Renan Coutinho2, Henrique S. Oliveira5, Livia Afonso2, Otávio Espíndola1, Ana Claudia Leite1, Abelardo Araujo1,6
1Laboratory of Clinical Research in Neuroinfections (LAPCLIN-NEURO), Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil
2Neurology Section, Hospital Universitário Clementino Fraga Filho, The Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
3Neurology Department, Complexo Hospitalar de Niterói, Niterói, Brazil
4Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil
5Hospital Julia Kubitschek, Belo Horizonte, Brazil
6Institute of Neurology, UFRJ, Rio de Janeiro, Brazil

Tóm tắt

COVID-19 pandemic revealed several neurological syndromes related to this infection. We describe the clinical, laboratory, and radiological features of eight patients with COVID-19 who developed peripheral facial palsy during infection. In three patients, facial palsy was the first symptom. Nerve damage resulted in mild dysfunction in five patients and moderate in three. SARS-Cov-2 was not detected in CSF by PCR in any of the samples. Seven out of eight patients were treated with steroids and all patients have complete or partial recovery of the symptoms. Peripheral facial palsy should be added to the spectrum of neurological manifestations associated with COVID-19.

Tài liệu tham khảo

Bigaut K, Mallaret M, Baloglu S et al (2020) Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 7. https://doi.org/10.1212/NXI.0000000000000785 Bremell D, Hagberg L (2011) Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell’s palsy). BMC Infect Dis 11:215. https://doi.org/10.1186/1471-2334-11-215 Casas E, Barbosa A, Rubio-García E et al (2020) Isolated peripheral facial paralysis in a patient with COVID-19. Rev Neurol 71:40–41. https://doi.org/10.33588/rn.7101.2020229 Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. Lancet Neurol. 19:767–783. https://doi.org/10.1016/S1474-4422(20)30221-0 Espíndola O d M, Siqueira M, Soares CN et al (2020) Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid. Int J Infect Dis. 96:567–569. https://doi.org/10.1016/j.ijid.2020.05.123 Goh Y, Beh DLL, Makmur A, Somani J, Chan ACY (2020) Pearls and oysters: facial nerve palsy as a neurological manifestation of Covid-19 infection. Neurology. 95:364–367. https://doi.org/10.1212/WNL.0000000000009863 House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147. https://doi.org/10.1177/019459988509300202 Jowett N (2018) A general approach to facial palsy. Otolaryngol Clin North Am 51:1019–1031. https://doi.org/10.1016/j.otc.2018.07.002 Juliao Caamaño DS, Alonso Beato R (2020) Facial diplegia, a possible atypical variant of Guillain-Barré syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci 77:230–232. https://doi.org/10.1016/j.jocn.2020.05.016 Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ, Kurland LT (1986) Incidence, clinical features, and prognosis in Bell’s palsy, Rochester, Minnesota, 1968-1982. Ann Neurol 20:622–627. https://doi.org/10.1002/ana.410200511 Manganotti P, Bellavita G, D’Acunto L et al (2020) Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain Barré syndrome and polyneuritis cranialis in COVID-19 patients: a case series. J Med Virol. https://doi.org/10.1002/jmv.26289 Nunes Duarte-Neto A, de Almeida Monteiro RA, da Silva LFF et al (2020) Pulmonary and systemic involvement of COVID-19 assessed by ultrasound-guided minimally invasive autopsy. Histopathology. 77:186–197. https://doi.org/10.1111/his.14160 Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, Guarrera GM, Giometto B (2020) Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci 41:1351–1354. https://doi.org/10.1007/s10072-020-04449-8 Owusu JA, Stewart CM, Boahene K (2018) Facial nerve paralysis. Med Clin North Am 102:1135–1143. https://doi.org/10.1016/j.mcna.2018.06.011 Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, Jayaseelan DL, Kumar G, Raftopoulos RE, Zambreanu L, Vivekanandam V, Khoo A, Geraldes R, Chinthapalli K, Boyd E, Tuzlali H, Price G, Christofi G, Morrow J, McNamara P, McLoughlin B, Lim ST, Mehta PR, Levee V, Keddie S, Yong W, Trip SA, Foulkes AJM, Hotton G, Miller TD, Everitt AD, Carswell C, Davies NWS, Yoong M, Attwell D, Sreedharan J, Silber E, Schott JM, Chandratheva A, Perry RJ, Simister R, Checkley A, Longley N, Farmer SF, Carletti F, Houlihan C, Thom M, Lunn MP, Spillane J, Howard R, Vincent A, Werring DJ, Hoskote C, Jäger HR, Manji H, Zandi MS, the UCL Queen Square National Hospital for Neurology and Neurosurgery COVID-19 Study Group (2020) The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. https://doi.org/10.1093/brain/awaa240 Paybast S, Gorji R, Mavandadi S (2020) Guillain-Barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. Neurologist 25:101–103. https://doi.org/10.1097/NRL.0000000000000291 Sancho-Saldaña A, Lambea-Gil Á, Liesa JLC, Caballo MRB, Garay MH, Celada DR, Serrano-Ponz M (2020) Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clin Med (Lond) 20:e93–e94. https://doi.org/10.7861/clinmed.2020-0213 Silberzahn P, Bouhamidi R, Zwain I, Gaillard JL, Martin B (1988) Testosterone blood content is regulated by testicular aromatization-conjugation in the stallion. Steroids 52:353–354. https://doi.org/10.1016/0039-128x(88)90143-2 Sullivan FM, Swan IRC, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F (2007) Early treatment with prednisolone or acyclovir in Bell’s palsy. N Engl J Med 357:1598–1607. https://doi.org/10.1056/NEJMoa072006 Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X (2020) The etiology of Bell’s palsy: a review. J Neurol 267:1896–1905. https://doi.org/10.1007/s00415-019-09282-4